Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type

NCT00190411 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT
CHROMOSOME 2q31.2 DELETION SYNDROME

Interventions

DRUG: celiprolol
DRUG: Control

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]